Annals of the Rheumatic Diseases


ISSN: 0003-4967        年代:1982
当前卷期:Volume 41  issue Suppl_1     [ 查看所有卷期 ]

年代:1982
 
     Volume 41  issue Suppl_1
     Volume 41  issue 1   
     Volume 41  issue 2   
     Volume 41  issue 3   
     Volume 41  issue 4   
     Volume 41  issue 5   
     Volume 41  issue 6   
1. The choice of, and the decision to apply, disease modifying drugs.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  1-2

C GBarnes,  

Preview   |   PDF (287KB)

2. Immunosuppression and the rheumatic diseases.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  3-8

A MDenman,  

Preview   |   PDF (971KB)

3. Differences among immunosuppressive agents.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  9-11

G HHitchings,  

Preview   |   PDF (286KB)

4. The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  12-17

B LHazleman,  

Preview   |   PDF (805KB)

5. Long-term effects of azathioprine in rheumatoid arthritis.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  18-22

M BUrowitz,   H ASmythe,   TAble,   C SNorman,   CTravis,  

Preview   |   PDF (720KB)

6. Interim observations on benefit/risk of azathioprine versus D-penicillamine in the treatment of rheumatoid arthritis.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  23-25

J RWard,   H JWilliams,  

Preview   |   PDF (318KB)

7. An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today*
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  26-29

Harold EPaulus,  

Preview   |   PDF (527KB)

8. EULAR register of patients on immunosuppressive drugs.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  30-31

AKay,  

Preview   |   PDF (179KB)

9. The incidence of malignant disease in patients receiving cytotoxic therapy for rheumatoid arthritis.
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  32-33

A BKirsner,   S JFarber,   R PSheon,   R IFinkel,  

Preview   |   PDF (237KB)

10. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis*
  Annals of the Rheumatic Diseases,   Volume  41,   Issue  Suppl_1,   1982,   Page  34-36

H AIsomäki,   THakulinen,   UJoutsenlahti,  

Preview   |   PDF (438KB)

首页 上一页 下一页 尾页 第1页 共16条